Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
MitchelsonKAJTranTTTDillonETVlckovaKHarrisonSMNtemiriAet al
6.3 Jiangsu Hengrui + Kailera Therapeutics Kailera Therapeutics was formed in 2024 as a U.S.-domiciled spin-out around a portfolio of incretin assets licensed from Jiangsu Hengrui, China's largest indigenous pharmaceutical company
Full article: Heather Hirsch MD MS MSCP , MHT first
With a comparison of its effects on other cell lineages Leuk
Their unusual sulfur chemistry and redox properties have recently attracted attention for pharmaceutical development
US$ 25.10
US$ 23.56
US$ 28.70
US$ 24.15
US$ 29.34
US$ 25.36
US$ 26.58
US$ 20.40
US$ 26.49
US$ 20.70
US$ 26.00
US$ 21.98
